DiaSorin S.p.A. (OTCMKTS:DSRLF – Get Free Report) shares gapped up before the market opened on Tuesday . The stock had previously closed at $68.33, but opened at $74.34. DiaSorin shares last traded at $74.34, with a volume of 300 shares trading hands.
Wall Street Analyst Weigh In
Separately, Morgan Stanley raised DiaSorin from an “underweight” rating to an “overweight” rating in a report on Tuesday, August 26th. Two investment analysts have rated the stock with a Buy rating, According to MarketBeat, DiaSorin presently has a consensus rating of “Buy”.
Read Our Latest Research Report on DiaSorin
DiaSorin Trading Up 7.0%
DiaSorin Company Profile
DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS.
Read More
- Five stocks we like better than DiaSorin
- Breakout Stocks: What They Are and How to Identify Them
- Higher Beef Prices Are Here: Best Steakhouse Stocks for 2026
- 3 Fintech Stocks With Good 2021 Prospects
- AI Runs on Power—And Constellation Energy Controls the Switch
- Best Stocks Under $5.00
- 3 Insider Moves You Shouldn’t Ignore Heading Into 2026
Receive News & Ratings for DiaSorin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DiaSorin and related companies with MarketBeat.com's FREE daily email newsletter.
